FIELD: veterinary medicine.
SUBSTANCE: invention relates to a veterinary composition that can be used to control iron deficiency and/or anemic conditions in a non-human mammal. The proposed veterinary composition contains an aqueous colloidal solution of beta-iron oxyhydroxide and glucopentonic acid dextran as the only active ingredient and polyvinylpyrrolidone.
EFFECT: use of polyvinylpyrrolidone provides increased antianemic efficacy and improved tissue distribution of the iron complex in non-human mammals.
14 cl
Title | Year | Author | Number |
---|---|---|---|
PHOSPHATE ADSORBENT BASED ON IRON (III) COMPOUNDS AND CARBOHYDRATES | 2007 |
|
RU2447933C2 |
DOSAGE FORM AND USE OF DIETHYLSTILBESTROL FOR TREATING PROSTATE CANCER OR BREAST CANCER | 2012 |
|
RU2602296C2 |
TRIAZINE FORMULATIONS WITH SECOND ACTIVE INGREDIENT AND SURFACTANT (-S) | 2013 |
|
RU2652136C2 |
PHARMACEUTICAL COMPOSITIONS | 2008 |
|
RU2493831C2 |
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC THERAPEUTIC AGENTS AND COMPOSITIONS CONTAINING IT | 2006 |
|
RU2429850C2 |
COMPOSITION FOR USE FOR SIMULTANEOUS TREATMENT OF COCCIDIAL INFECTIONS AND IRON DEFICIENCY ANEMIAS | 2019 |
|
RU2828711C2 |
COMPOSITIONS CONTAINING RECOMBINANT PROTEASE INHIBITOR, METHODS FOR PREPARATION AND USE THEREOF | 2019 |
|
RU2826190C2 |
PHOSPHATE ADSORBENT | 2010 |
|
RU2527682C2 |
PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC MEDICINAL PRODUCTS AND COMPOSITIONS CONTAINING THEM | 2006 |
|
RU2623206C2 |
PHARMACEUTICAL COMPOSITION COMPRISING IRON OXY-HYDROXIDE, METHOD OF PRODUCTION THEREOF AND USE | 2013 |
|
RU2648760C2 |
Authors
Dates
2024-01-29—Published
2019-05-16—Filed